Ambys Medicines' Corporate Minority Round

Ambys Medicines raised a round of funding on August 08, 2018. Investors include Takeda Pharmaceutical.

Ambys Medicines is a developer of regenerative medicine therapies for serious liver diseases.…

Articles about Ambys Medicines' Corporate Minority Round: